A new study investigating the link between cerebral microbleeds (CMBs) and dementia has found that the location and pattern of these brain lesions are critical to assessing risk. Analyzing data from over 1,500 participants in the ARIC-Neurocognitive Study, researchers classified individuals based on their CMB patterns—lobar, subcortical, or mixed—and tracked dementia incidence. The results showed that participants with microbleeds in the lobar regions, which often indicate cerebral amyloid angiopathy, or a mixed pattern of bleeds had roughly double the risk of developing dementia compared to those with no CMBs. In contrast, individuals with microbleeds restricted to subcortical areas, typically linked to hypertension, did not show a significantly increased risk. The presence of cortical superficial siderosis (cSS) was associated with an even higher risk, and overall, a greater number of microbleeds anywhere in the brain correlated with higher dementia risk. The findings suggest that while the underlying cause of microbleeds matters, a severe disease burden is detrimental regardless of its location. Source: https://www.ahajournals.org/
The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…
Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…
Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…
Escitalopram, duloxetine, and agomelatine achieved higher sustained response rates than fluoxetine, while escitalopram and duloxetine…
Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…
In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…
This website uses cookies.